Amelioration of high dose cyclophosphamide-induced myelosuppression
Charak, B.S.
National Medical Journal of India 4(1): 30
1991
ISSN/ISBN: 0970-258X PMID: 29751480 Document Number: 379605
Document emailed within 1 workday
Related Documents
Alberts, D.S. 1999: Protection by amifostine of cyclophosphamide-induced myelosuppression Seminars in Oncology 26(2 Suppl 7: 37-40Khoo, K.S.; Ang, P.T. 1995: Extract of astragalus membranaceus and ligustrum lucidum does not prevent cyclophosphamide-induced myelosuppression Singapore Medical Journal 36(4): 387-390
Gardner, S.F.; Lazarus, H.M.; Bednarczyk, E.M.; Creger, R.J.; Miraldi, F.D.; Leisure, G.; Green, J.A. 1993: High-dose cyclophosphamide-induced myocardial damage during BMT: assessment by positron emission tomography Bone Marrow Transplantation 12(2): 139-144
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Lu, Y.S.; Kermani-Arab, V.; Moll, T. 1976: Cyclophosphamide-induced amelioration of Marek's disease in Marek's disease-susceptible chickens American Journal of Veterinary Research 37(6): 687-692
Shepp, M.; Necheles, T.F.; Banks, H.H.; Oh, W.H.; Zimbler, S. 1978: Adjuvant treatment of osteogenic sarcoma with high-dose cyclophosphamide Cancer Treatment Reports 62(2): 295-296
Fasola, G.; Lo Greco, P.; Calori, E.; Zilli, M.; Verlicchi, F.; Motta, M.R.; Ricci, P.; Baccarani, M.; Tura, S. 1991: Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation Haematologica 76(2): 120-125
Mittal, G.; Balakrishnan, C.; Mangat, G.; Joshi, V.R. 1999: High dose cyclophosphamide in the treatment of systemic lupus erythematosus Journal of the Association of Physicians of India 47(7): 747
Piver, M.S.; Barlow, J.J.; Chung, W.S. 1975: High-dose cyclophosphamide (NSC-26271) for recurrent or progressive ovarian adenocarcinoma Cancer ChemoTherapy Reports 59(6): 1157-1158
Ettinger, D.S.; Karp, J.E.; Abeloff, M.D.; Burke, P.J.; Braine, H.G. 1978: Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung Cancer Treatment Reports 62(3): 413-424
Tremann, J.A.; Haines, J.G.; Bleifuss, J.H.; Agodoa, L.C.; Marchioro, T.L. 1975: The effect of high dose steroid and cyclophosphamide on perfused canine renal homografts Transplantation 19(6): 520-522
Depledge, M.H. 1984: Dose-independence of early, cyclophosphamide-induced lung damage in mice Japanese Journal of Experimental Medicine 54(6): 235-239
Patrone, F.; Ballestrero, A.; Balleari, E.; Bogliolo, F.; Brema, F.; Ferrando, F.; Ghio, R.; Timitilli, S. 1992: High-dose cyclophosphamide followed by GM-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells Haematologica 77(6): 457-462
Carter, J.L.; Hafler, D.A.; Dawson, D.M.; Orav, J.; Weiner, H.L. 1988: Immunosuppression with high-dose I.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients Neurology 38(7 Suppl 2: 9-14
Leung, F.K.; Fortin, P.R. 2003: Intravenous cyclophosphamide and high dose corticosteroids improve MRi lesions in demyelinating syndrome in systemic lupus erythematosus Journal of Rheumatology 30(8): 1871-1873
Wada, N.; Kobayashi, H.; Oka, S.; Ando, J.; Tamura, H. 2002: Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(11): 1935-1942
Mizuno, H.; Ninomiya, N.; Ohta, H.; Tokoro, K.; Yasuma, A.; Ohnishi, K.; Ikeda, Y. 1983: Treatment of multiple myeloma. High-dose intermittent administration of cyclophosphamide and prednisolone--follow up study of 10 years period Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(11): 2286-2291
Siena, S.; Bregni, M.; Bonsi, L.; Sklenar, I.; Bagnara, G.P.; Bonadonna, G.; Gianni, A.M. 1993: Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors Experimental Hematology 21(12): 1583-1590
Pantel, K.; Nakeff, A. 1989: Cyclophosphamide-induced enhancement of stem cell recovery from whole-body irradiation is radiation dose-dependent Experimental Hematology 17(7): 847-850
Sola, C.; Mendoza, L.; Amill, B.; Mesía, R.; Rueda, A.; Alonso, M.C.; Ojeda, B.; Artigas, V.; Tugues, D.; García, J. 1995: Intensive chemotherapy with support of peripheral hematopoietic progenitor cells, mobilized with high-dose cyclophosphamide and G-CSF: fast hematologic recovery Revista Clinica Espanola 195(2): 83-88